Abstract
Background
Familial adenomatous polyposis (FAP) patients are at risk for numerous malignancies. Multiple surgeries exist to mitigate the risk of colorectal cancer. Surgeons must weigh future quality of life versus the risk of dysplasia. As FAP patient longevity increases, there remains a risk of other malignancies. This study examines surgical interventions, development of cancers, and causes of mortality in a FAP registry.
Methods
Patients with FAP or attenuated FAP (aFAP) were identified by linking the Hereditary Gastrointestinal Cancer Registry with University of Utah’s medical records. Patients without sufficient information were excluded. Patient demographics, surgical histories, cancer diagnoses, and causes of death were extracted. Logrank and Fisher’s exact tests were employed to detect significant differences between groups.
Results
After exclusion criteria, 140 patients were analyzed. Sixty patients (42.9%) underwent total proctocolectomy with ileal pouch-anal anastomosis (IPAA) followed by 50 (35.7%) having total colectomy with ileorectal anastomosis (IRA). IPAA patients were more likely female (p = 0.01) and have FAP (p < 0.01) versus IRA patients. Nineteen patients (15.0%) required additional colorectal surgeries; however, no differences were based on initial surgery. Colorectal cancer was diagnosed in 22 patients (15.7%), while 7 (5.0%) developed gastric cancer. Of the 15 deceased patients, 6 (40%) died due to gastric adenocarcinoma.
Discussion
This study suggests that aFAP and FAP patients are undergoing appropriate colorectal interventions to reduce colorectal cancer mortality; however, repeat interventions are frequent. Gastric malignancy is common and represents the leading cause of death. Further studies are needed to determine appropriate surveillance protocols to reduce this risk of malignancy.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11605-019-04412-9/MediaObjects/11605_2019_4412_Fig1_HTML.png)
Similar content being viewed by others
References
Lockhart-Mummery, J.P. Dis Colon Rectum 1984;27: 208
Phillips R, Clark SK. Polyposis Syndromes. In: Wolf BC, Fleshman JW, Beck DE, Pemberton JH, Wexner SD. The ASCRS Textbook of Colon and Rectal Surgery. New York: Springer, 2007;373–384
Spigelman AD, Williams CB, Talbot IC, Domizio P, Phillips RK. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 1989;2(8666):783–785
Jarrar AM, Milas M, Mitchell J, Laguardia L, O’Malley M, Berber E, Siperstein A, Burke C, Church JM. Screening for thyroid cancer in patients with familial adenomatous polyposis. Ann Surg 2011;252:515–521
National Comprehensive Cancer Network (2015) NCCN Clinical Practice Guidelines in Oncology: Genetic/Familial High-Risk Assessment: Colorectal. Version 2.2015. Fort Washington, PA: National Comprehensive Cancer Network
Vasen HFA, Moslen G, Alonso A, Aretz S, Bernstein I, Bertario L, Blanco I, Bulow S, Burn J, Capella G, Colas C, Engel C, Frayling I, Friedl W, Hes FJ, Hodgson S, Jarvinen H, Mecklin JP, Moller P, Myrhoi T, Nagengast FM, Parc Y, Phillips R, Clark SK, de Leon MP, Renkonen-Sinisalo L, Sampson JR, Stormorken A, Tejpar S, Thomas HJ, Wijnen J.. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 2008;57:704–713
da Luz Moreira A, Kiran RP, Lavery I. Clinical outcomes of ileorectal anastomosis for ulcerative colitis. Br J Surg 2010;97:65–69
Andersson P, Norblad R, Söderholm JD, Myrelid P. Ileorectal anastomosis in comparison with ileal pouch anal anastomosis in reconstructive surgery for ulcerative colitis--a single institution experience. J Crohns Colitis 2014;8:582–589
Koskenvuo L, Renkonen-Sinisalo L, Jarvinen HJ, Lepisto A. Risk of cancer and secondary proctectomy after colectomy and ileorectal anastomosis in familial adenomatous polyposis. Int J Colorectal Dis 2014;29(2):225–30
Barrow P, Khan M, Lalloo F, Evans DG, Hill J. Systematic review of the impact of registration and screening on colorectal cancer incidence and mortality in familial adenomatous polyposis and Lynch syndrome. Br J Surg 2013;100: 1719–1731
Walton SJ, Frayling IM, Clark SK. Gastric tumours in FAP. Fam Cancer 2017;16:363–369
Wood LD, Salaria SN, Cruise MW, Giardiello FM, Montgomery EA. Upper GI tract lesions in familial adenomatous polyposis (FAP): enrichment of pyloric gland adenomas and other gastric and duodenal neoplasms. Am J Surg Pathol 2014;38:389–393
Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW, American College of Gastroenterology. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol 2015;110:223–262
Jagelman DG, DeCosse JJ, Bussey HJ. Upper gastrointestinal cancer in familial adenomatous polyposis. Lancet 1988;1:1149–1150
Mankaney G, Leone P, Cruise M, LaGuardia L, O’Malley M, Bhatt A, Church J, Burke CA. Gastric cancer in FAP: a concerning rise in incidence. Fam Cancer. 2017:16:371–376
Author information
Authors and Affiliations
Contributions
Authors Cannon, Neklason, and Pickron equally contributed to the conception and interpretation of this study. Author Keener was responsible for data acquisition, data fidelity, and assistance with data interpretation. Author Cannon was responsible for data organization and analysis. Author Cannon was responsible for creation of the initial written draft while authors Keener, Neklason, and Pickron were all equally involved in draft revisions and final submission.
Corresponding author
Ethics declarations
All aspects of this study were approved by the University of Utah’s Institutional Review Board for human subject research.
Conflict of Interest
The authors declare that they have no conflicts of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Cannon, A.R., Keener, M., Neklason, D. et al. Surgical Interventions, Malignancies, and Causes of Death in a FAP Patient Registry. J Gastrointest Surg 25, 452–456 (2021). https://doi.org/10.1007/s11605-019-04412-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-019-04412-9